Target intelligence / Profile preview

Cationic amino acid transporter 1-4 (CAT1-4)

Target
CAT1-4
Molecular classification
Transporter, Solute carrier family, SLC7 family
01

Overview

The cationic amino acid transporter (CAT) family, comprising CAT-1 (SLC7A1), CAT-2 (SLC7A2), CAT-3 (SLC7A3), and CAT-4 (SLC7A4), consists of integral membrane proteins that facilitate the sodium-independent transport of basic amino acids such as L-arginine, L-lysine, and L-histidine across cell membranes. These transporters are essential for cellular homeostasis, providing substrates for protein synthesis and serving as the primary source of arginine for the production of nitric oxide and polyamines. CAT-1 is ubiquitously expressed and acts as a high-affinity transporter, while CAT-2 exists in two isoforms: CAT-2A (low-affinity, high-capacity, primarily in the liver) and CAT-2B (high-affinity, inducible in macrophages and during inflammation). CAT-3 is predominantly expressed in the brain, and CAT-4 remains largely uncharacterized regarding its transport activity. In clinical contexts, members like CAT-1 and CAT-2 are often overexpressed in various cancers to sustain rapid cell proliferation and are being investigated as potential therapeutic targets. Additionally, CAT-1 serves as the cellular receptor for ecotropic murine leukemia viruses, highlighting its significance in virology. Drugs targeting these transporters aim to modulate nutrient uptake in tumors or control nitric oxide-mediated inflammatory responses.

Other names
SLC7A1SLC7A2SLC7A3SLC7A4Solute carrier family 7 member 1-4System y+ basic amino acid transporterEcotropic retroviral leukemia receptor homologATRC1ATRC2
02

Mechanism of action

The cationic amino acid transporters (CATs) function as sodium-independent, pH-insensitive facilitated diffusers that mediate the equilibrative transport (entry and efflux) of basic amino acids across the plasma membrane.

03

Biological functions

Facilitated diffusion of cationic amino acidsSodium-independent transportL-Arginine uptake for nitric oxide synthesisL-Arginine uptake for polyamine synthesisAmino acid sensing (mTORC1 pathway)Protein synthesis
04

Disease associations

CancerInflammationHypertensionAsthmaViral infection (Ecotropic murine leukemia virus)Cardiovascular disease
05

Safety considerations

Essential amino acid depletionAlteration of systemic nitric oxide levelsPotential for hypotension due to excessive nitric oxide productionImpact on polyamine-dependent cell growth
06

Interacting drugs

L-Arginine

4 more in the full profile.

07

Biomarkers

SLC7A1 expression levelSLC7A2 expression levelArginine-to-ornithine ratioIntracellular arginine concentration

Beyond the preview

Go deeper on Cationic amino acid transporter 1-4 (CAT1-4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cationic amino acid transporter 1-4 (CAT1-4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call